<DOC>
	<DOCNO>NCT01652833</DOCNO>
	<brief_summary>To ensure appropriate administration Vectibix treatment mCRC wild-type KRAS real-world practice , important understand awareness practice oncologist regard correct indication appropriate administration Vectibix . It also critical monitor change oncologist ' awareness practice different round study .</brief_summary>
	<brief_title>European Physician Survey EGFR Inhibitor Prescribing Patterns</brief_title>
	<detailed_description>The survey conduct 3 round month 0 , 12 , 24 first interview . Before begin round , sample list create Amgen . In round survey , potential participate oncologist sample country 's sample list random sample reach telephone , letter email . During initial contact , oncologist assess eligibility participate study use standardized screening questionnaire . The initial contact screen potential participating oncologist continue total 150 eligible oncologist agree participate round . The number oncologist sample country proportional use Vectibix country number oncology physician estimate prescribe Vectibix . Each eligible oncologist participate 1 3 round survey . Study staff conduct survey identify eligible oncologist telephone , use standardized questionnaire . Information awareness correct indication appropriate administration Vectibix experience administration Vectibix treatment previous 6 month collect . We make every attempt collect correct information participate oncologist . This may require least two phone call allow oncologist review note order report correct data .</detailed_description>
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<criteria>Physician Must practice oncology specialist Must treat least 3 new continue patient metastatic colorectal cancer last quarter Must prescribe Vectibix within last 6 month metastatic colorectal cancer patient Must take part study previously Must participate Amgen study number 20101120 .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2016</verification_date>
	<keyword>Metastatic Colorectal Cancer</keyword>
</DOC>